# Copaiba (Copaifera langsdorffii)

**Canonical URL:** https://ingredients.hermeticasuperfoods.com/ingredients/copaiba-copaifera-langsdorffii
**Data Source:** Hermetica Superfoods Ingredient Encyclopedia
**Updated:** 2026-03-18
**Evidence Score:** 4 / 10
**Category:** South American
**Also Known As:** Copaifera langsdorffii, Copaifera reticulata, Copaifera officinalis, Copaiba balsam, Brazilian copaiba, Amazonian copaiba, Copal, Bálsamo de copaíba

## Overview

Copaiba (Copaifera langsdorffii) is a Brazilian tree that produces oleoresin rich in β-caryophyllene, a sesquiterpene that selectively activates CB2 cannabinoid receptors. This compound provides [anti-inflammatory](/ingredients/condition/inflammation) effects by modulating endocannabinoid signaling pathways without psychoactive properties.

## Health Benefits

- Reduces [inflammation](/ingredients/condition/inflammation) by inhibiting enzymes like COX-2, which can help alleviate chronic pain conditions. - Enhances skin health by promoting [collagen production](/ingredients/condition/skin-health), leading to improved skin elasticity and reduced signs of aging. - Supports respiratory health by acting as a bronchodilator, which can ease symptoms of asthma. - Boosts mood and reduces anxiety by modulating [neurotransmitter activity](/ingredients/condition/cognitive), providing a natural way to enhance mental well-being. - Exhibits [antimicrobial](/ingredients/condition/immune-support) properties, effectively combating bacteria and fungi, which supports skin and wound health. - May improve gut health by reducing intestinal inflammation, which aids in [digestion](/ingredients/condition/gut-health) and nutrient absorption. - Supports [cardiovascular health](/ingredients/condition/heart-health) by lowering blood pressure and improving circulation, reducing the risk of heart disease.

## Mechanism of Action

β-caryophyllene in copaiba selectively binds to CB2 cannabinoid receptors, modulating immune responses and reducing inflammatory cytokine production. The compound also inhibits COX-2 enzymes and 5-lipoxygenase pathways, decreasing [prostaglandin](/ingredients/condition/inflammation) E2 and leukotriene synthesis. Additionally, it stimulates fibroblast activity and [collagen synthesis](/ingredients/condition/skin-health) while acting as a bronchodilator through smooth [muscle relaxation](/ingredients/condition/sleep).

## Clinical Summary

Human studies on copaiba are limited, with most research conducted in animal models and cell cultures. A small pilot study (n=30) showed 40% reduction in inflammatory markers after 8 weeks of topical copaiba application. Animal studies demonstrate significant [anti-inflammatory](/ingredients/condition/inflammation) effects with 200-400mg/kg doses, while in vitro research confirms COX-2 inhibition rates of 60-80%. More randomized controlled trials are needed to establish definitive human efficacy and optimal dosing protocols.

## Nutritional Profile

Copaiba resin/oil is not a significant source of macronutrients or conventional micronutrients, as it is used therapeutically rather than as a food. Its primary bioactive compounds are sesquiterpenes, with beta-caryophyllene (BCP) comprising 30–80% of the resin's volatile fraction — the highest natural concentration of BCP found in any plant source. Other notable sesquiterpenes include alpha-copaene (5–15%), beta-bisabolene (2–10%), and delta-cadinene (2–8%). The resin also contains diterpene acids (copalic acid, kaurenoic acid, hardwickiic acid) at approximately 10–30% of total resin weight, which contribute to its [anti-inflammatory](/ingredients/condition/inflammation) and [antimicrobial](/ingredients/condition/immune-support) activity. Beta-caryophyllene is a full agonist at CB2 cannabinoid receptors (EC50 ~155 nM), making it highly bioavailable via oral and topical routes. Kaurenoic acid demonstrates selective cytotoxic and anti-inflammatory properties. The essential oil form retains predominantly sesquiterpene fractions, while the crude oleoresin contains both volatile and resin acid fractions. Bioavailability of BCP is enhanced in lipid-based delivery systems due to its lipophilic nature.

## Dosage & Preparation

Copaiba oil can be used topically, diluted with a carrier oil, or taken internally in capsule form, typically 1-2 drops per day. Consult a healthcare provider before use.

## Safety & Drug Interactions

Copaiba is generally well-tolerated with mild side effects including occasional skin irritation when applied topically. No significant drug interactions have been reported, though theoretical interactions may occur with anticoagulant medications due to potential blood-thinning properties. Pregnant and breastfeeding women should avoid use due to insufficient safety data. Individuals with tree allergies should exercise caution and perform patch tests before topical application.

## Scientific Research

Copaiba oil has been studied for its [anti-inflammatory](/ingredients/condition/inflammation) and analgesic properties, with some promising results in animal studies. Human clinical trials, including RCTs, are limited, and further research is needed to confirm these effects.

## Historical & Cultural Context

Traditionally used by indigenous tribes of the Amazon, Copaiba has been valued for its healing properties, particularly for skin conditions and pain relief. It is an integral part of the region's natural medicine practices.

## Synergistic Combinations

Copaiba pairs strongly with Frankincense (Boswellia serrata) because both target the COX-2 and 5-LOX [inflammatory pathway](/ingredients/condition/inflammation)s — BCP via CB2 receptor activation and boswellic acids (AKBA) via direct 5-LOX inhibition — creating complementary, additive anti-inflammatory suppression across multiple enzyme cascades. Black Pepper (Piper nigrum) is a powerful synergist due to its piperine content (~5–9% in extract), which inhibits CYP3A4 and P-glycoprotein efflux pumps, enhancing the bioavailability and tissue retention of BCP and the diterpene acids by up to 20–30%. Turmeric (Curcuma longa) complements Copaiba through parallel NF-κB pathway suppression — curcumin (95% extract) inhibits NF-κB transcription factors while BCP modulates CB2-mediated signaling that also suppresses NF-κB activation, providing upstream and downstream blockade of the inflammatory cascade. Lavender (Lavandula angustifolia) extends the anxiolytic synergy, as linalool's GABA-A modulation complements BCP's CB2-mediated reduction in neuroinflammation and anxiety signaling, producing additive calming effects without sedative overload.

## Frequently Asked Questions

### How much β-caryophyllene is in copaiba oil?

Copaiba oleoresin typically contains 40-70% β-caryophyllene by weight, making it one of the richest natural sources of this cannabinoid compound. High-quality copaiba oils should contain at least 50% β-caryophyllene for therapeutic effectiveness.

### What's the difference between copaiba and CBD?

Copaiba's β-caryophyllene selectively activates CB2 receptors without binding to CB1 receptors, avoiding psychoactive effects entirely. CBD interacts with both CB1 and CB2 receptors plus other pathways, while copaiba provides more targeted anti-inflammatory action through the endocannabinoid system.

### How long does copaiba take to work for inflammation?

Topical copaiba applications may provide relief within 30-60 minutes for localized inflammation. For systemic anti-inflammatory effects, oral supplementation typically requires 2-4 weeks of consistent use at 200-400mg daily doses to achieve measurable results.

### Can copaiba help with arthritis pain?

Animal studies suggest copaiba's β-caryophyllene reduces joint inflammation and pain scores by 50-60% through CB2 receptor activation and COX-2 inhibition. However, human clinical trials for arthritis are lacking, and results may vary significantly between individuals.

### Is copaiba safe for daily long-term use?

Current research suggests copaiba is safe for daily use up to 6 months, with no reported toxicity in animal studies at therapeutic doses. However, long-term human safety data beyond 6 months is limited, so periodic breaks or medical supervision is recommended for extended use.

### Does copaiba interact with blood thinners or anticoagulant medications?

Copaiba may have mild anticoagulant properties due to its volatile oil compounds, which could potentially interact with blood thinners like warfarin or aspirin. If you are taking anticoagulant medications, consult your healthcare provider before adding copaiba supplements to avoid increased bleeding risk. Medical supervision is recommended to monitor for any adverse interactions.

### What is the most effective form of copaiba supplement—oil, capsule, or tincture?

Copaiba oil (oleoresin) is considered the most bioavailable form as it contains the full spectrum of active compounds including β-caryophyllene and other sesquiterpenes in their natural ratios. Capsules offer convenience and standardized dosing but may have reduced absorption compared to direct oil consumption. Tinctures provide intermediate bioavailability and allow for flexible dosing adjustments.

### Is copaiba safe for children, and at what age can it be used?

There is limited safety data on copaiba use in children, and most manufacturers recommend it for adults only. The internal use of copaiba oil in pediatric populations has not been well-studied, making it prudent to avoid supplementation in children without explicit pediatric guidance from a qualified healthcare provider. Topical application may have different safety considerations than oral ingestion.

---

*Source: Hermetica Superfoods Ingredient Encyclopedia — https://ingredients.hermeticasuperfoods.com*
*License: CC BY-NC-SA 4.0 — Attribution required. Commercial use: admin@hermeticasuperfoods.com*